Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

926
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
926
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

845
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
845
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

719
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standalone bio-interventional uveoscleral outflow enhancement for intraocular pressure reduction in open-angle glaucoma: One-year results from a prospective multicenter real-world evidence study (NCT05506423).

PloS one·2026
Same author

Mitochondrial and microtubule defects in Exfoliation Glaucoma.

Free radical biology & medicine·2025
Same author

Mitochondrial and Microtubule Defects in Exfoliation Glaucoma.

bioRxiv : the preprint server for biology·2024
Same author

Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.

American journal of ophthalmology case reports·2023
Same author

Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of Guatemala.

International journal of environmental research and public health·2021
Same author

Is Multiple Sclerosis Associated With a Lower Intraocular Pressure?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2017

Related Experiment Video

Updated: Sep 28, 2025

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.3K

Uveitis-Glaucoma-Hyphema Syndrome Following iStent Implantation.

Adam Siedlecki1, Bhumi Kinariwala2, Sandra Sieminski3

  • 1Department of Ophthalmology, University at Buffalo, Buffalo, New York, USA.

Case Reports in Ophthalmology
|March 30, 2022
PubMed
Summary

Minimally invasive glaucoma surgery (MIGS) using iStent can cause rare complications like recurrent hyphema. Removing the iStent resolved symptoms in one patient, highlighting potential risks and management strategies.

Keywords:
GlaucomaImplant removalMinimally invasive glaucoma surgeryRecurrent hyphemaUveitis-glaucoma-hyphema syndromeiStent

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.5K
A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.6K

Related Experiment Videos

Last Updated: Sep 28, 2025

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.3K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.5K
A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
07:00

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

10.6K

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Medical Device Complications

Background:

  • Minimally invasive glaucoma surgery (MIGS) offers a safer alternative to traditional glaucoma procedures.
  • iStent implantation is a common MIGS technique used concurrently with cataract surgery.

Observation:

  • A patient developed recurrent spontaneous microhyphema and inflammation post-iStent implantation and cataract surgery.
  • Exfoliation syndrome was noted, potentially causing zonular weakness and anterior lens-iris diaphragm movement.
  • Extensive workup ruled out conventional causes for recurrent hyphema.

Findings:

  • iStent-iris interaction was suspected as the cause of microtrauma, leading to recurrent hyphema.
  • iStent removal and OMNI canaloplasty resulted in complete symptom resolution without hyphema recurrence.
  • This case highlights a potential complication of iStent use in patients with specific anatomical predispositions.

Implications:

  • MIGS devices, including iStents, may have rare but significant complications.
  • Careful patient selection and monitoring are crucial for MIGS procedures.
  • iStent explantation can be an effective treatment for specific device-related complications.